Abstract
Anaphylactic reactions are a known complication in some IgA-deficient patients receiving blood or plasma transfusions. It is of particular interest that anaphylaxis has been observed in patients with common variable immunodeficiency (CVID) who are receiving intravenous gammaglobulin (IVIG), and in that, although these patients have an impaired response to common vaccines, they retain the ability to produce autoantibodies. In this study, we review IgA antibodies (both IgG- and IgE-mediated reactions) in patients with CVID and hypogammaglobulinemia, anaphylaxis in antibody immunodeficient patients receiving IVIG, and proposed mechanisms of desensitization and prevention of anaphylactic reactions in immunodeficient patients receiving IVIG. We summarize and assess the 23 case reports documented in the literature that have described anaphylactic reactions in immunodeficient patients receiving IVIG since 1962 until currently, and make a comparison of their immunoglobulin levels, IgG anti-IgA, IgE anti-IgA, concentration of IVIG, IgA content in IVIG, method used to detect antibodies, length of treatment, and any subsequent tolerated treatment documented.
Similar content being viewed by others
References
Ahrens N, Höflich C, Bombard S et al (2008) Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment. Clin Exp Immunol 151:455–458
Barandun S, Isliker H (1986) Development of immunoglobulin preparations for intravenous use. Vox Sang 51:157–160
Barandun S, Kistler P, Jeunet F et al (1962) Intravenous administration of human gamma-globulin. Vox Sang 7:157–174
Bjerrum OJ, Jersild C (1971) Class-specific anti-IgA associated with severe anaphylactic transfusion reactions in a patient with pernicious anaemia. Vox Sang 21:411–424
Björkander J, Hammarström L, Smith CI et al (1987) Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies. J Clin Immunol 7:8–15
Burks AW, Sampson HA, Buckley RH (1986) Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N Engl J Med 314:560–564
Cohn EJ (1945) Blood proteins and their therapeutic value. Science 101:51–56
Cunningham-Rundles C, Zhou Z, Mankarious S et al (1993) Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies. J Clin Immunol 13:272–278
de Albuquerque Campos R, Sato MN, da Silva Duarte AJ (2000) IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy. J Clin Immunol 20:77–82
Domen RE, Hoeltge GA (2003) Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med 127:316–320
Eijkhout HW, van den Broek PJ, van der Meer JW (2003) Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy. Neth J Med 61:213–217
Ferreira A, Garcia Rodriguez MC, Lopez-Trascasa M et al (1988) Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin. Clin Immunol Immunopathol 47:199–207
Gallagher PE, Buckley RH (1962) Anaphylactic reactions and anti-IgA antibodies in common variable agammaglobulinemia: IgA deficient plasma treatment. J Allergy Clin Immunol 69:120
Hedderich U, Kratzsch G, Stephen W et al (1986) Immunoglobulin substitution therapy in a patient with primary hypogammaglobulinaemia and anti-IgA antibodies. Clin Allergy 16:339–344
Horn J, Thon V, Bartonkova D et al (2007) Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy. Clin Immunol 122:156–162
Kiani-Alikhan S, Yong PF, Grosse-Kreul D et al (2010) Successful desensitization to immunoglobulin A in a case of transfusion-related anaphylaxis. Transfusion 50:1897–1901
Kleinman S, Chan P, Robillard P (2003) Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 17:120–162
Klemperer MR, Donaldson VH, Rosen FS (1968) Effect of C’1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema. J Clin Invest 47:604–611
Marcus DM (1960) A study of the mechanism of the anticomplementary activity of gamma-globulin. J Immunol 84:273–284
Oltean S, Epure A, Lindström K et al (2014) Detection of anti-IgA antibodies using the particle gel immunoassay: a rapid test for increased patient safety. Blood Transfus 12:334–339
Oxelius VA, Laurell AB, Lindquist B et al (1981) IgG subclasses in selective IgA deficiency: importance of IgG2-IgA deficiency. N Engl J Med 304:1476–1477
Pereira LF, Sapiña AM, Arroyo J et al (1997) Prevalence of selective IgA deficiency in Spain: more than we thought. Blood 90:893
Petty RE, Palmer NR, Cassidy JT et al (1979) The association of autoimmune diseases and anti-IgA antibodies in patients with selective IgA deficiency. Clin Exp Immunol 37:83–88
Pineda AA, Taswell HF (1975) Transfusion reactions associated with anti-IgA antibodies: report of four cases and review of the literature. Transfusion 15:10–15
Rachid R, Castells M, Cunningham-Rundles C et al (2011) Association of anti-IgA antibodies with adverse reactions to γ-globulin infusion. J Allergy Clin Immunol 128(228–230):e1
Salama A, Schwind P, Schönhage K et al (2001) Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay. Vox Sang 81:45–48
Salama A, Temmesfeld B, Hippenstiel S et al (2004) A new strategy for the prevention of IgA anaphylactic transfusion reactions. Transfusion 44:509–511
Sandler SG, Eckrich R, Malamut D et al (1994) Hemagglutination assays for the diagnosis and prevention of IgA anaphylactic transfusion reactions. Blood 84:2031–2035
Sandler SG, Mallory D, Malamut D et al (1995) IgA anaphylactic transfusion reactions. Transfus Med Rev 9:1–8
Strait RT, Morris SC, Finkelman FD (2006) IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking. J Clin Invest 116:833–841
Sundin U, Nava S, Hammarström L (1998) Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy. Clin Exp Immunol 112:341–346
Vamvakas EC, Pineda AA (2001) Allergic and anaphylactic reactions. In: Popovsky MA (ed) Transfusion reactions, 2nd edn. American Association of Blood Banks Press, Bethesda, pp 83–127. http://uci.worldcat.org/title/transfusion-reactions/oclc/122715432
van der Heijden J, Geissler J, van Mirre E et al (2013) A novel splice variant of FcγRIIa: a risk factor for anaphylaxis in patients with hypogammaglobulinemia. J Allergy Clin Immunol 131(1408–1416):e5
Vassallo RR (2004) Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence, and supply of IgA-deficient products. Immunohematology 20:226–233
Vyas GN, Perkins HA, Fudenberg HH (1968) Anaphylactoid transfusion reactions associated with anti-IgA. Lancet 2:312–315
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Williams, S.J., Gupta, S. Anaphylaxis to IVIG. Arch. Immunol. Ther. Exp. 65, 11–19 (2017). https://doi.org/10.1007/s00005-016-0410-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-016-0410-1